Clinical Trial Update: A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the potential drug-drug interaction between IDX320 and IDX184 in healthy participants, related to chronic hepatitis C, and the trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• IDX184 (IDX184)
• IDX320

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C | Phase 1 | Status: COMPLETED